KR102592759B1 - 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 - Google Patents
이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 Download PDFInfo
- Publication number
- KR102592759B1 KR102592759B1 KR1020237001032A KR20237001032A KR102592759B1 KR 102592759 B1 KR102592759 B1 KR 102592759B1 KR 1020237001032 A KR1020237001032 A KR 1020237001032A KR 20237001032 A KR20237001032 A KR 20237001032A KR 102592759 B1 KR102592759 B1 KR 102592759B1
- Authority
- KR
- South Korea
- Prior art keywords
- functional group
- functional groups
- bifunctional modified
- reaction
- carboxylic acid
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 108
- 229920001222 biopolymer Polymers 0.000 title claims abstract description 99
- 230000001588 bifunctional effect Effects 0.000 title claims abstract description 79
- 239000000017 hydrogel Substances 0.000 title claims abstract description 55
- 125000000524 functional group Chemical group 0.000 claims abstract description 172
- 229920000159 gelatin Polymers 0.000 claims abstract description 66
- 235000019322 gelatine Nutrition 0.000 claims abstract description 66
- 108010010803 Gelatin Proteins 0.000 claims abstract description 62
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 62
- 239000008273 gelatin Substances 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 45
- 238000004132 cross linking Methods 0.000 claims abstract description 42
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 150000003254 radicals Chemical group 0.000 claims abstract description 19
- 238000007156 chain growth polymerization reaction Methods 0.000 claims abstract description 16
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 74
- 125000003277 amino group Chemical group 0.000 claims description 54
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 50
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 14
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 14
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 claims description 13
- 150000001718 carbodiimides Chemical class 0.000 claims description 9
- 230000008878 coupling Effects 0.000 claims description 9
- 238000010168 coupling process Methods 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 7
- 229920001567 vinyl ester resin Polymers 0.000 claims description 6
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical group C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical group NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- ZKJNETINGMOHJG-GGWOSOGESA-N (e)-1-[(e)-prop-1-enoxy]prop-1-ene Chemical group C\C=C\O\C=C\C ZKJNETINGMOHJG-GGWOSOGESA-N 0.000 claims description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical group C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 125000002009 alkene group Chemical group 0.000 claims 1
- 125000004185 ester group Chemical group 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 239000000463 material Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- FYGUSUBEMUKACF-UHFFFAOYSA-N bicyclo[2.2.1]hept-2-ene-5-carboxylic acid Chemical compound C1C2C(C(=O)O)CC1C=C2 FYGUSUBEMUKACF-UHFFFAOYSA-N 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- 230000008901 benefit Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- XLBALIGLOMYEKN-UHFFFAOYSA-N 5-bicyclo[2.2.1]hept-2-enylmethanamine Chemical compound C1C2C(CN)CC1C=C2 XLBALIGLOMYEKN-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 7
- 238000007306 functionalization reaction Methods 0.000 description 7
- -1 methacryl anhydride Chemical class 0.000 description 7
- 150000003141 primary amines Chemical group 0.000 description 7
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical compound O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 4
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000004971 Cross linker Substances 0.000 description 4
- 239000001828 Gelatine Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 238000007872 degassing Methods 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- 150000002148 esters Chemical group 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000005292 vacuum distillation Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 2
- GFPIDSQKIMZWHT-UHFFFAOYSA-N 7-methyl-4-sulfanylchromen-2-one Chemical compound CC1=CC=C2C(=CC(OC2=C1)=O)S GFPIDSQKIMZWHT-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 150000001336 alkenes Chemical group 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000012650 click reaction Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000001459 lithography Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- BYDNGJQDDNBAHI-UHFFFAOYSA-N 4-methyl-7-sulfanylchromen-2-one Chemical compound C1=C(S)C=CC2=C1OC(=O)C=C2C BYDNGJQDDNBAHI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 239000011557 critical solution Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- JFNLZVQOOSMTJK-UHFFFAOYSA-N norbornene Chemical compound C1C2CCC1C=C2 JFNLZVQOOSMTJK-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N ornithyl group Chemical group N[C@@H](CCCN)C(=O)O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007155 step growth polymerization reaction Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0033—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0038—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
- C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18175368.2 | 2018-05-31 | ||
| EP18175368 | 2018-05-31 | ||
| KR1020207036164A KR20210030903A (ko) | 2018-05-31 | 2019-05-29 | 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 |
| PCT/EP2019/063995 WO2019229140A1 (en) | 2018-05-31 | 2019-05-29 | Bifunctional modified biopolymer based polymers and hydrogels obtainable from such bifunctional modified biopolymer based polymers |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207036164A Division KR20210030903A (ko) | 2018-05-31 | 2019-05-29 | 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20230013155A KR20230013155A (ko) | 2023-01-26 |
| KR102592759B1 true KR102592759B1 (ko) | 2023-10-20 |
Family
ID=62683091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237001032A KR102592759B1 (ko) | 2018-05-31 | 2019-05-29 | 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 |
| KR1020207036164A KR20210030903A (ko) | 2018-05-31 | 2019-05-29 | 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020207036164A KR20210030903A (ko) | 2018-05-31 | 2019-05-29 | 이작용성 변형된 생체중합체 기반 중합체 및 이러한 이작용성 변형된 생체중합체 기반 중합체로부터 수득 가능한 하이드로겔 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210198433A1 (zh) |
| EP (1) | EP3802703A1 (zh) |
| JP (1) | JP7204154B2 (zh) |
| KR (2) | KR102592759B1 (zh) |
| CN (1) | CN112543791B (zh) |
| AU (2) | AU2019276160B2 (zh) |
| BR (1) | BR112020024128A2 (zh) |
| CA (1) | CA3101402C (zh) |
| EA (1) | EA202092832A1 (zh) |
| WO (1) | WO2019229140A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3185350A1 (en) * | 2020-06-19 | 2021-12-23 | Universiteit Gent | Swellable gelatin compositions |
| CN111743857A (zh) * | 2020-07-30 | 2020-10-09 | 瑞希(重庆)生物科技有限公司 | 一种壳聚糖水凝胶及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006034128A2 (en) | 2004-09-17 | 2006-03-30 | Angiotech Biomaterials Corporation | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3401949A1 (de) * | 1984-01-20 | 1985-08-01 | Bayer Ag, 5090 Leverkusen | Norbornan- und norbornencarbonsaeureamide, verfahren zu deren herstellung sowie die verwendung von norbornan- und norbornencarbonsaeureamiden als arzneimittel |
| WO2003031483A1 (en) * | 2001-10-10 | 2003-04-17 | The Regents Of The University Of Colorado | Degradable thiol-ene polymers |
| ITMI20061726A1 (it) * | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
| KR20100125187A (ko) * | 2009-05-20 | 2010-11-30 | 히다치 가세고교 가부시끼가이샤 | 카르복실기 함유 (메타)아크릴산에스테르 및 그 제조방법 |
| WO2011088213A1 (en) * | 2010-01-15 | 2011-07-21 | University Of Utah Research Foundation | Crosslinked hydrogels and methods of making and using thereof |
| EP2661283B1 (en) * | 2011-01-04 | 2019-03-27 | GATT Technologies B.V. | Cross-linked polymers and implants derived from electrophilically activated polyoxazoline |
| US8980295B2 (en) * | 2011-03-02 | 2015-03-17 | Wisconsin Alumni Research Foundation | Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry |
| BR112014007993A2 (pt) * | 2011-10-03 | 2017-04-04 | Synthes Gmbh | polimerização de tioleno com ésteres vinílicos e vinilcarbonato |
| AT515955B1 (de) * | 2014-06-16 | 2016-08-15 | Universität Linz | Polymerstruktur und dreidimensionales Gerüst für die Gewebezüchtung |
| JP2016197548A (ja) * | 2015-04-03 | 2016-11-24 | 日東シンコー株式会社 | 電気絶縁用樹脂組成物 |
| WO2017095240A1 (en) * | 2015-12-02 | 2017-06-08 | Lim Shen Khoon | Light-activated preparation of hydrogels |
| US20190298851A1 (en) * | 2016-06-01 | 2019-10-03 | The Texas A&M University System | Sequential click reactions for the synthesis and functionalization of hydrogel microspheres and substrates |
| CN107213523B (zh) * | 2017-06-13 | 2020-06-05 | 苏州大学附属第一医院 | 一种促进成骨生长的共交联双网络水凝胶支架的制备方法 |
| CN111378082B (zh) * | 2018-12-30 | 2021-10-22 | 中国科学院沈阳自动化研究所 | 一种双基团光敏明胶的制备方法和应用 |
-
2019
- 2019-05-29 CA CA3101402A patent/CA3101402C/en active Active
- 2019-05-29 KR KR1020237001032A patent/KR102592759B1/ko active IP Right Grant
- 2019-05-29 WO PCT/EP2019/063995 patent/WO2019229140A1/en unknown
- 2019-05-29 CN CN201980036357.6A patent/CN112543791B/zh active Active
- 2019-05-29 US US17/058,368 patent/US20210198433A1/en active Pending
- 2019-05-29 BR BR112020024128-8A patent/BR112020024128A2/pt unknown
- 2019-05-29 AU AU2019276160A patent/AU2019276160B2/en active Active
- 2019-05-29 EA EA202092832A patent/EA202092832A1/ru unknown
- 2019-05-29 EP EP19726443.5A patent/EP3802703A1/en active Pending
- 2019-05-29 KR KR1020207036164A patent/KR20210030903A/ko active Application Filing
- 2019-05-29 JP JP2020566940A patent/JP7204154B2/ja active Active
-
2022
- 2022-08-03 AU AU2022211848A patent/AU2022211848B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006034128A2 (en) | 2004-09-17 | 2006-03-30 | Angiotech Biomaterials Corporation | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
Also Published As
| Publication number | Publication date |
|---|---|
| US20210198433A1 (en) | 2021-07-01 |
| EA202092832A1 (ru) | 2021-03-01 |
| CN112543791B (zh) | 2023-06-30 |
| EP3802703A1 (en) | 2021-04-14 |
| AU2019276160A1 (en) | 2021-01-14 |
| JP2021525305A (ja) | 2021-09-24 |
| AU2022211848B2 (en) | 2024-05-30 |
| JP7204154B2 (ja) | 2023-01-16 |
| WO2019229140A1 (en) | 2019-12-05 |
| CN112543791A (zh) | 2021-03-23 |
| CA3101402A1 (en) | 2019-12-05 |
| CA3101402C (en) | 2023-09-12 |
| AU2019276160B2 (en) | 2022-08-18 |
| BR112020024128A2 (pt) | 2021-02-17 |
| KR20210030903A (ko) | 2021-03-18 |
| AU2022211848A1 (en) | 2022-08-25 |
| KR20230013155A (ko) | 2023-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Petta et al. | Hyaluronic acid as a bioink for extrusion-based 3D printing | |
| Fan et al. | Hybrid printing using cellulose nanocrystals reinforced GelMA/HAMA hydrogels for improved structural integration | |
| AU2022211848B2 (en) | Bifunctional modified biopolymer based polymers and hydrogels obtainable from such bifunctional modified biopolymer based polymers | |
| EP3043835B1 (en) | Transparent hydrogel and method of making the same from functionalized natural polymers | |
| US10046087B2 (en) | Collagen based materials | |
| US20220305718A1 (en) | Universal Orthogonal Network Bioinks for Three-Dimensional Bioprinting | |
| CN114349990B (zh) | 一种动态特性可调水凝胶及其制备方法与应用 | |
| CN114874455B (zh) | 一种中性溶解、具有自组装能力和光交联能力的改性胶原和凝胶的构建方法 | |
| Tran et al. | Emerging silk fibroin materials and their applications: new functionality arising from innovations in silk crosslinking | |
| Raj et al. | A cholecystic extracellular matrix‐based hybrid hydrogel for skeletal muscle tissue engineering | |
| CN113975462B (zh) | 一种多巴胺功能化的神经活性水凝胶的制备方法 | |
| Stubbe et al. | Photo‐crosslinked gelatin‐based hydrogel films to support wound healing | |
| Nguyen et al. | Oxidation-mediated scaffold engineering of hyaluronic acid-based microcarriers enhances corneal stromal regeneration | |
| Dutta et al. | Trackable and highly fluorescent nanocellulose-based printable bio-resins for image-guided tissue regeneration | |
| KR102315457B1 (ko) | 버크홀데리아 유래 티로시나아제를 이용하여 제조된 접착력을 가지는 가교 결합 물질, 그의 제조 방법 및 그의 응용 | |
| Allasia et al. | Methacrylated zein as a novel biobased macro-crosslinker for PVCL hydrogels | |
| EP4338763A1 (en) | A process for 3d bioprinting utilizing a hydrogel comprising a water-soluble elastin derivative | |
| KR102684221B1 (ko) | 고치환도 키토산 유도체를 이용한 3d 바이오프린팅용 바이오잉크 조성물의 제조방법 | |
| KR102634670B1 (ko) | 히알루론산-콜라겐 기반 3d 바이오잉크 조성물 | |
| KR20230106823A (ko) | 고치환도 키토산 유도체를 이용한 3d 바이오프린팅용 바이오잉크 조성물의 제조방법 | |
| Kafili et al. | Development of bioinspired nanocomposite bioinks based on decellularized amniotic membrane and hydroxyethyl cellulose for skin tissue engineering | |
| Saffirio | Synthesis and characterization of physically cross-linked GrapheneOxide (GO)/Collagen hydrogels for tissue engineering | |
| JP2024509177A (ja) | 架橋性バイオポリマーの製造方法 | |
| Faria-Tischer et al. | Bio-based nanocomposites: strategies for cellulose functionalization and tissue | |
| WO2022079678A1 (en) | Method for the production of biocompatible nanomaterials with selective recognition capabilities and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |